Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis
Open Access
- 3 May 2022
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 12 (5) , 595
Abstract
Salivary Aβ40, Aβ42, t-tau, and p-tau 181 are commonly employed in Alzheimer’s disease (AD) investigations. However, the collection method of these biomarkers can affect their levels. To assess the impact of saliva collection methods on biomarkers in this study, 15 healthy people were employed in the morning with six saliva collection methods. The chosen methods were then applied in 30 AD patients and 30 non-AD controls. The levels of salivary biomarkers were calculated by a specific enzyme-linked immunosorbent assay. The receiver operating characteristic was utilized to assess salivary biomarkers in AD patients. The results demonstrated that the highest levels of salivary Aβ40, Aβ42, t-tau, and p-tau were in different saliva collection methods. The correlations between different saliva biomarkers in the same collection method were different. Salivary Aβ40, Aβ42, t-tau, and p-tau had no significant association. Salivary Aβ42 was higher in AD than in non-AD controls. However, p-tau/t-tau and Aβ42/Aβ40 had some relevance. The area under the curve for four biomarkers combined in AD diagnosis was 92.11%. An alternate saliva collection method (e.g., USS in Aβ40, UPS in Aβ42, t-tau, SSS in p-tau 181) was demonstrated in this study. Moreover, combining numerous biomarkers improves AD diagnosis.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (2020B1515120082, JCYJ20190807144001746, JSGG20191129114422849, 20180309163834680)
- Innovation Commission of Science and Technology of Shenzhen Municipality (2020B1515120082, JCYJ20190807144001746, JSGG20191129114422849, 20180309163834680)
- shenzhen municipal industrial and information technology bureau (2020B1515120082, JCYJ20190807144001746, JSGG20191129114422849, 20180309163834680)
This publication has 87 references indexed in Scilit:
- Role of Amyloid from a Multiple Sclerosis Perspective: A Literature ReviewNeuroimmunomodulation, 2015
- Non-Invasive Screening for Alzheimer’s Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) BiosensorPLOS ONE, 2015
- The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassaysClinical and Translational Medicine, 2012
- Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic MechanismsAntioxidants & Redox Signaling, 2012
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's diseaseBrain, 2006
- MRI and CSF studies in the early diagnosis of Alzheimer's diseaseJournal of Internal Medicine, 2004
- Oxidative stress in neurodegeneration: cause or consequence?Nature Medicine, 2004
- Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsyMovement Disorders, 2002
- Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's DiseaseJournal of Cell Biology, 1998